Compare ACHV & KINS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ACHV | KINS |
|---|---|---|
| Founded | N/A | 1886 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 172.0M | 205.7M |
| IPO Year | 2018 | 2013 |
| Metric | ACHV | KINS |
|---|---|---|
| Price | $4.80 | $18.57 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $15.50 | N/A |
| AVG Volume (30 Days) | ★ 882.6K | 96.5K |
| Earning Date | 05-12-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 1.13% |
| EPS Growth | N/A | ★ 94.59 |
| EPS | N/A | ★ 2.88 |
| Revenue | N/A | ★ $214,867,301.00 |
| Revenue This Year | N/A | $24.23 |
| Revenue Next Year | N/A | $18.05 |
| P/E Ratio | ★ N/A | $6.14 |
| Revenue Growth | N/A | ★ 38.50 |
| 52 Week Low | $1.96 | $13.08 |
| 52 Week High | $6.03 | $22.20 |
| Indicator | ACHV | KINS |
|---|---|---|
| Relative Strength Index (RSI) | 71.66 | 80.07 |
| Support Level | $4.06 | $14.08 |
| Resistance Level | $5.30 | N/A |
| Average True Range (ATR) | 0.28 | 0.71 |
| MACD | 0.18 | 0.45 |
| Stochastic Oscillator | 83.08 | 85.13 |
Achieve Life Sciences Inc is a late-stage clinical specialty pharmaceutical company with the sole mission to address the nicotine dependence epidemic through the development and commercialization of cytisinicline. Cytisinicline, is a naturally occurring alkaloid. Additionally, The company has completed a Phase 2 study with cytisinicline in vaping cessation and conducted a successful end-of-Phase 2 meeting with the FDA for a future vaping indication. It operates in one operating segment, development and commercialization of cytisinicline for nicotine dependence, with operations located in Canada, the United States and the U.K.
Kingstone Companies Inc offers property and casualty insurance products through its subsidiary engaged in writing business through retail and wholesale agents and brokers. Its products include Personal lines, Livery physical damage, and Others. It operates in single segment, property and casualty insurance. It derives substantially all of its revenue from KICO, including revenues from earned premiums, ceding commissions from quota share reinsurance, net investment income generated from its investment portfolio, and net realized gains and losses on investment securities.